Back to results
US 10,292,961 B2Granted
Disulfur bridge linkers for conjugation of a cell-binding molecule
AssigneeHangzhou Dac Biotech Co., Ltd.
InventorRobert Yongxin Zhao
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel disulfur bridge linkers containing hydrazine used for the specific conjugation of compounds/cytotoxic agents to a cell-binding molecule, through bridge linking a pair of thiols on the cell-binding molecule. The invention also relates to methods of making such linkers, and of using such linkers in making homogeneous conjugates, as well as of application of the conjugates in treatment of cancers, infections and autoimmune disorders.
Claims13
A bridge linker compound of Formula (I)
- wherein:
- Y1 and Y2 are the same or different and represent a functional group that enables reaction of the bridge linker compound with a pair of sulfur atoms of a cell-binding agent, to form disulfide, thioether, or thioester bonds, the function group for Y1 and Y2 being a N-hydroxysuccinimide ester, maleimide, disulfide, haloacetyl, ethenesulfonyl, acryl(acryloyl), 2-(tosyloxy)acetyl, 2-(mesyloxy)acetyl, 2-(nitrophenoxy)acetyl, 2-(dinitrophenoxy)acetyl, 2-(fluorophenoxy)-acetyl, 2-(difluorophenoxy)-acetyl, 2-(pentafluorophenoxy)acetyl, 2-(((trifluoromethyl)-sulfonyl)oxy)-acetyl, or acid anhydride group, as shown below:
- N-hydroxysuccinimide ester;
- maleimide;
- disulfide;
- haloacetyl;
- ethenesulfonyl;
- acryl (acryloyl);
- 2-tosyloxy)acetyl;
- 2-mesyloxy)acetyl;
- 2-nitrophenoxy)acetyl;
- 2-(dinitrophenoxy)acetyl;
- 2-(fluorophenoxy)-acetyl;
- 2-(difluorophenoxy)-acetyl;
- 2-(pentafluorophenoxy)acetyl;
- methylsulfone phenyloxadiazole (ODA);
- (((trifluoromethyl)-sulfonyl)oxy)acetyl;
- acid anhydride,
- wherein X1 is F, Cl, Br, I or Lv;
- X2 is O, NH, N(R1′), or CH2;
- R5 is R1′, aromatic, heteroaromatic, or aromatic group wherein one or several H atoms are replaced independently by —R1′, -halogen, —OR1′, —SR1′, —NR1′R2′, —NO2, —S(O)R1′, —S(O)2R1′, or —COOR1′;
- Lv is a leaving group selected from the group consisting of nitrophenol;
- N-hydroxysuccinimide (NHS);
- phenol;
- dinitrophenol;
- pentafluorophenol;
- tetrafluorophenol;
- difluorophenol;
- monofluorophenol;
- pentachlorophenol;
- triflate;
- imidazole;
- dichlorophenol;
- tetrachlorophenol;
- 1-hydroxybenzotriazole;
- tosylate;
- mesylate;
- and 2-ethyl-5-phenylisoxazolium-3′-sulfonate;
- R1′ and R2′ are the same or different, and are H, a linear alkyl having from 1 to 8 carbon atoms, branched or cyclic alkyl having from 3 to 8 carbon atoms, linear, branched or cyclic alkenyl or alkynyl having from 2 to 8 carbon atoms, or an ester, ether or amide having 2 to 8 carbon atoms;
- Z1 and Z2 are the same or different and represent a function group of a thiol, disulfide, amino, carboxy, aldehyde, ketone, maleimido, haloacetyl, hydrazine, alkoxyamino, or hydroxy group;
- R1, R2, R3 and R4 are the same or different, and are absent, or a chain of atoms selected from the group consisting of C, N, O, S, Si, and P, which covalently connects to Y1 or Y2 or Z1 or Z2.
38 more elements
A bridge linker compound of Formula (I)
- wherein:
- Y1 and Y2 are the same or different and represent a functional group that enables reaction of the bridge linker compound with a pair of sulfur atoms of a cell-binding agent, to form disulfide, thioether, or thioester bonds, the function group for Y1 and Y2 being a N-hydroxysuccinimide ester, maleimide, disulfide, haloacetyl, ethenesulfonyl, acryl(acryloyl), 2-(tosyloxy)acetyl, 2-(mesyloxy)acetyl, 2-(nitrophenoxy)acetyl, 2-(dinitrophenoxy)acetyl, 2-(fluorophenoxy)-acetyl, 2-(difluorophenoxy)-acetyl, 2-(pentafluorophenoxy)acetyl, 2-(((trifluoromethyl)-sulfonyl)oxy)-acetyl, or acid anhydride group, as shown below:
- N-hydroxysuccinimide ester;
- maleimide;
- disulfide;
- haloacetyl;
- ethenesulfonyl;
- acryl (acryloyl);
- 2-tosyloxy)acetyl;
- 2-mesyloxy)acetyl;
- 2-nitrophenoxy)acetyl;
- 2-(dinitrophenoxy)acetyl;
- 2-(fluorophenoxy)-acetyl;
- 2-(difluorophenoxy)-acetyl;
- 2-(pentafluorophenoxy)acetyl;
- methylsulfone phenyloxadiazole (ODA);
- (((trifluoromethyl)-sulfonyl)oxy)acetyl;
- acid anhydride,
- wherein X1 is F, Cl, Br, I or Lv;
- X;
- is O, NH, N(R1′), or CH2;
- R5 is R1′, aromatic, heteroaromatic, or aromatic group wherein one or several H atoms are replaced independently by —R1′, -halogen, —OR1′, —SR1′, —NR1′R1′, —NO2, —S(O)R1′, —S(O)2R1′, or —COOR1′;
- Lv is a leaving group selected from the group consisting of nitrophenol;
- N-hydroxysuccinimide (NHS);
- phenol;
- dinitrophenol pentafluorophenol;
- tetrafluorophenol;
- difluorophenol;
- monofluorophenol;
- pentachlorophenol;
- triflate;
- imidazole;
- dichlorophenol;
- tetrachlorophenol;
- 1-hydroxybenzotriazole;
- tosylate;
- mesylate;
- and 2-ethyl-5-phenylisoxazolium-3′-sulfonate;
- R1′ and R2′ are the same or different, and are H, a linear alkyl having from 1 to 8 carbon atoms, branched or cyclic alkyl having from 3 to 8 carbon atoms, linear, branched or cyclic alkenyl or alkynyl having from 2 to 8 carbon atoms, or an ester, ether or amide having 2 to 8 carbon atoms;
- Z1 and Z2 are the same or different and represent a function group of a thiol, disulfide, amino, carboxy, aldehyde, ketone, maleimido, haloacetyl, hydrazine, alkoxyamino, or hydroxy group;
- R1, R2, R3 and R4 are the same or different, and are one or more linker components selected from the group consisting of 6-maleimidocaproyl (MC)
- maleimido propanoyl (MP)
- valine-citrulline (val-cit), alanini-phenylalanine (ala-phe), lysine-phenylalanine (lys-Phe), p-amidobenzyloxycarbonyl (PAB)
- 4-thio-pentanoate (SPP)
- 4-(N-maleimidomethyl)-cyclohexane-1-carboxylate (MCC)
- 4-thio-butyrage (SPDB)
- maleimidoethyl (ME)
- 4-thio-2-hydroxysulfonyl-butyrate (2-Sulfo-SPDB)
- alkoxy amino (AOA), ethyleneoxy (EO) —CH2CH2O—, 4-methyl-4-dithio-pentanoic (MPDP)
- alkynyl —C═C—, dithio —S—S—, peptides containing 1˜25 aminoacids, and (4-acetyl)aminobenzoate (SIAB)
47 more elements
Dependencies are inferred from the claim text.